[1] |
马远征, 王以朋, 刘强, 等. 中国老年骨质疏松症诊疗指南(2018)[J]. 中国实用内科杂志, 2019, 39(1): 38-61. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201901012.htmMA YZ, WANG YP, LIU Q, et al. 2018 China guideline for diagnosis and treatment of senile osteoporosis[J]. Chin J Pract Intern Med, 2019, 39(1): 38-61. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201901012.htm
|
[2] |
中华人民共和国国家统计局. 中国统计年鉴2015[M]. 北京: 中国统计出版社, 2015.National Bureau of Statistics, PRC. China Statistical Yearbook 2015[M]. Beijing: China statistical publishing house, 2015.
|
[3] |
Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society[J]. Menopause, 2010, 17(1): 25-56.
|
[4] |
陈芳, 张宜, 徐立. 中西医治疗绝经后骨质疏松症的研究进展[J]. 医药导报, 2021, 40(9): 1216-1220. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202109013.htmCHEN F, ZHANG Y, XU L. Research progress of traditional Chinese and western medicine in the treatment of postmenopausal osteoporosis[J]. Herald Med, 2021, 40(9): 1216-1220. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202109013.htm
|
[5] |
闫慧明, 郭静, 安燕, 等. 分子信号通路在骨质疏松症发生机制中的研究进展[J]. 中国骨质疏松杂志, 2016, 22(10): 1336-1340. doi: 10.3969/j.issn.1006-7108.2016.10.024YAN HM, GUO J, AN Y, et al. Research progress in molecular signaling pathways on the pathogenesis of osteoporosis[J]. Chin J Osteoporos, 2016, 22(10): 1336-1340. doi: 10.3969/j.issn.1006-7108.2016.10.024
|
[6] |
王林, 李平, 贾海峰, 等. 兔骨缺损ESW治疗后成骨细胞中VEGF的表达[J]. 中国当代医药, 2009, 16(13): 23-24. doi: 10.3969/j.issn.1674-4721.2009.13.012WANG L, LI P, JIA HF, et al. Expression of VEGF on the osteoblast after extracorporeal shock wave (ESW) for the treatment of rabbits bone defect[J]. China Mod Med, 2009, 16(13): 23-24. doi: 10.3969/j.issn.1674-4721.2009.13.012
|
[7] |
XU H, YANG JJ, WANG CH, et al. Effect of Wnt/β-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis[J]. Clin Exp Obstet Gynecol, 2016, 43(4): 573-577. doi: 10.12891/ceog3053.2016
|
[8] |
LI ZN, YUAN GX, LIN XX, et al. Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosis[J]. Biochem Pharmacol, 2019, 163: 279-289. doi: 10.1016/j.bcp.2019.02.002
|
[9] |
DU D, ZHOU ZB, ZHU L, et al. TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis[J]. Bone, 2018, 117: 161-170. doi: 10.1016/j.bone.2018.09.012
|
[10] |
PARK E, LIM E, YEO S, et al. Anti-menopausal effects of Cornus officinalis and Ribes fasciculatumextract in vitro and in vivo[J]. Nutrients, 2020, 12(2): E369. doi: 10.3390/nu12020369
|
[11] |
FAIENZA MF, VENTURA A, MARZANO F, et al. Postmenopausal osteoporosis: The role of immune system cells[J]. Clin Dev Immunol, 2013, 2013: 575936.
|
[12] |
STERN AR, YAO XM, WANG Y, et al. Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats[J]. Bone Rep, 2018, 8: 115-124. doi: 10.1016/j.bonr.2018.02.005
|
[13] |
LEVIN VA, JIANG X, KAGAN R. Estrogen therapy for osteoporosis in the modern era[J]. Osteoporos Int, 2018, 29(5): 1049-1055. doi: 10.1007/s00198-018-4414-z
|
[14] |
ZHU SY, DENG Y, WANG YF, et al. Bone protection for early menopausal women in China: Standard or half-dose estrogen with progestin?A one-year prospective randomized trail[J]. Gynecol Endocrinol, 2019, 35(2): 165-169. doi: 10.1080/09513590.2018.1505849
|
[15] |
TAHAMI M, HADDAD B, ABTAHIAN A, et al. Potential role of local estrogen in enhancement of fracture healing: Preclinical study in rabbits[J]. Arch Bone Jt Surg, 2016, 4(4): 323-329.
|
[16] |
SANTEN RJ, SIMPSON E. History of estrogen: Its purification, structure, synthesis, biologic actions, and clinical implications[J]. Endocrinology, 2018, 160(3): 605-625.
|
[17] |
NASOMYONT N, HORNUNG LN, GORDON CM, et al. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review[J]. Bone, 2019, 121: 60-67. doi: 10.1016/j.bone.2019.01.003
|
[18] |
杨茜, 张毅, 张元琛, 等. 强骨合剂联合西药治疗糖尿病骨质疏松症临床观察[J]. 宁夏医学杂志, 2015, 37(3): 281-283. https://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201503042.htmYANG X, ZHANG Y, ZHANG YC, et al. Clinical observation of qianggu mixture combined with western medicine in treating diabetic osteoporosis[J]. Ningxia Med J, 2015, 37(3): 281-283. https://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201503042.htm
|
[19] |
鄂远. 强骨合剂治疗糖尿病合并骨质疏松症的临床观察[J]. 糖尿病新世界, 2018, 21(20): 93-94. https://www.cnki.com.cn/Article/CJFDTOTAL-TNBX201820047.htmER Y. Clinical observation on treatment of diabetes mellitus with osteoporosis with strong bone mixture[J]. Diabetes New World, 2018, 21(20): 93-94. https://www.cnki.com.cn/Article/CJFDTOTAL-TNBX201820047.htm
|
[20] |
王雨辰, 刘百伟, 李云峰, 等. 强骨合剂治疗肾虚血瘀型骨质疏松症的临床研究[J]. 中医药导报, 2016, 22(23): 94-95, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201623031.htmWANG YC, LIU BW, LI YF, et al. Clinical research on kidney-deficiency and blood-stasis type osteoporosis by qianggu heji[J]. Guid J Tradit Chin Med Pharm, 2016, 22(23): 94-95, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201623031.htm
|
[21] |
王雨辰, 李云峰, 吴小伟, 等. 强骨合剂治疗肾虚血瘀型原发性骨质疏松症[J]. 长春中医药大学学报, 2015, 31(6): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201506043.htmWANG YC, LI YF, WU XW, et al. Treatment of kidney-deficiency and blood-stasis type osteoporosis with Qianggu Decoction[J]. J Changchun Univ Chin Med, 2015, 31(6): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201506043.htm
|
[22] |
李万森. 强骨合剂治疗糖尿病骨质疏松症疗效观察[J]. 山东医药, 2009, 49(35): 91-92. doi: 10.3969/j.issn.1002-266X.2009.35.040LI WS. Observation on therapeutic effect of Qianggu mixture on diabetic osteoporosis[J]. Shandong Med J, 2009, 49(35): 91-92. doi: 10.3969/j.issn.1002-266X.2009.35.040
|
[23] |
LEUCHT P, HELMS JA. Wnt signaling: An emerging target for bone regeneration[J]. J Am Acad Orthop Surg, 2015, 23(1): 67-68. doi: 10.5435/JAAOS-23-01-67
|
[24] |
BOONANANTANASARN K, LEE HL, BAEK K, et al. EGF inhibits Wnt/β-catenin-induced osteoblast differentiation by promoting β-catenin degradation[J]. J Cell Biochem, 2015, 116(12): 2849-2857. doi: 10.1002/jcb.25231
|
[25] |
REYA T, CLEVERS H. Wnt signalling in stem cells and cancer[J]. Nature, 2005, 434(7035): 843-850. doi: 10.1038/nature03319
|
[26] |
KATO M, PATEL MS, LEVASSEUR R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor[J]. J Cell Biol, 2002, 157(2): 303-314. doi: 10.1083/jcb.200201089
|
[27] |
GONG YQ, SLEE RB, FUKAI NM, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development[J]. Cell, 2001, 107(4): 513-523. doi: 10.1016/S0092-8674(01)00571-2
|
[28] |
王燕, 刘岩, 马剑侠, 等. Wnt/LRP5/β-catenin信号通路在绝经后骨质疏松发病中的作用[J]. 中华妇产科杂志, 2011, 46(10): 769-772. doi: 10.3760/cma.j.issn.0529-567x.2011.10.012WANG Y, LIU Y, MA JX, et al. Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis[J]. Chin J Obstet Gynecol, 2011, 46(10): 769-772. doi: 10.3760/cma.j.issn.0529-567x.2011.10.012
|
[29] |
MILLER JR. The wnts[J]. Genome Biol, 2002, 3(1): 3001.
|
[30] |
NUSSE R. Wnt signaling in disease and in development[J]. Cell Res, 2005, 15(1): 28-32. doi: 10.1038/sj.cr.7290260
|
[31] |
MACDONALD BT, TAMAI K, HE X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases[J]. Dev Cell, 2009, 17(1): 9-26. doi: 10.1016/j.devcel.2009.06.016
|
[32] |
LICHTLEN P, LAM TT, NORK TM, et al. Relative contribution of VEGF and TNF-α in the cynomolgus laser-induced CNV model: Comparing the efficacy of bevacizumab, adalimumab, and ESBA105[J]. Invest Ophthalmol Vis Sci, 2010, 51(9): 4738-4745. doi: 10.1167/iovs.09-4890
|
[33] |
HU Y, CHEN Y, LIN MK, et al. Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization[J]. Invest Ophthalmol Vis Sci, 2013, 54(1): 141-154. doi: 10.1167/iovs.12-10281
|
[34] |
KATOH Y, KATOH M. Comparative integromics on VEGF family members[J]. Int J Oncol, 2006, 28(6): 1585-1589.
|
[35] |
ZHANG X, GASPARD JP, CHUNG DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia[J]. Cancer Res, 2001, 61(16): 6050-6054.
|
[36] |
WANG Y, SANG AM, ZHU MH, et al. Tissue factor induces VEGF expression via activation of the Wnt/β-catenin signaling pathway in ARPE-19 cells[J]. Mol Vis, 2016, 22: 886-897.
|